Previous 10 | Next 10 |
2023-09-01 08:42:36 ET Aditxt ( ADTX ) -49% announces $10.0 Million private placement priced at-the-market under Nasdaq rules. iCoreConnect ( ICCT ) -22% . Flora Growth Corp. ( FLGC ) -17% . Biodexa Pharmaceuticals ( BDRX ) -15% . Tingo ...
2023-09-01 02:14:15 ET Aditxt ( NASDAQ: ADTX ) stock price dipped 48% on the purchase and sale of an aggregate of 1M shares at a purchase price of $10.00 per share in a private placement priced at the market under Nasdaq rules. Each share of common stock is being offered...
Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,000...
2023-08-30 10:00:13 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare ( XLV ) Tech Ruled The First Half Of 2023, The Industry You Need To Watch In The Second Half XLV Vs. VHT: A Head-To-Head Healthcare ETF C...
2023-08-28 13:25:50 ET Gainers: Mobile Infrastructure Corp ( OTC:MBIC ) +88% . Hersha Hospitality Trust ( HT ) +56% . GD Culture Group Limited ( GDC ) +45% . Genius Group Limited ( GNS ) +44% . Hawaiian Electric Industries ( HE ) +...
2023-08-23 13:11:49 ET Gainers: VCI Global Limited ( VCIG ) +107% . Mercurity Fintech Holding ( MFH ) +44% . Apellis Pharmaceuticals ( APLS ) +32% . iTeos Therapeutics ( ITOS ) +27% . Hitek Global ( HKIT ) +26% . Aditxt ( A...
Aditxt, Inc. (NASDAQ: ADTX) is one of today's top gainers. The company's shares are currently up 26.87% on the day to $12.7. Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune reprogramming and monitoring. It develops Adit...
2023-08-21 13:08:17 ET Gainers: Timber Pharmaceuticals ( TMBR ) +97% . China SXT Pharmaceuticals ( SXTC ) +92% . Novo Integrated Sciences ( NVOS ) +43% . Orchestra BioMed Holdings ( OBIO ) +27% . AlloVir ( ALVR ) +26% . The G...
2023-08-21 11:52:45 ET More on Health Care Select Sector SPDR XLV Vs. VHT: A Head-To-Head Healthcare ETF Comparison XLV: The Powerhouse ETF Driving Health And Wealth BlackRock spotlights healthcare as an opportunity with recession talks in the air Goldman add...
2023-08-18 13:14:27 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of biotechnology firm Aditxt (NASDAQ: ADTX ) — which specializes in therapeutics and technologies that monitor and modulate the immune system — popped up 25% on...
News, Short Squeeze, Breakout and More Instantly...
ADiTx Therapeutics Inc. Company Name:
ADTX Stock Symbol:
NASDAQ Market:
ADiTx Therapeutics Inc. Website:
SAN DIEGO, July 25, 2024 (GLOBE NEWSWIRE) -- Women’s health innovator Evofem Biosciences, Inc. (“Evofem” or “the Company”) (OTCQB: EVFM) today announced that Saundra Pelletier, Chief Executive Officer and Amy Raskopf, Chief Business Development Officer...
Appili, with a commercial-stage pipeline, has raised CAD $100M towards developing therapeutics for the global infectious disease and biodefense markets. Subject to the renewal of certain legislation, two programs are potentially eligible for FDA Priority Review Vouchers Aditxt, Inc. (...
Evofem Biosciences Inc. (OTCQB: EVFM) , a company commercializing innovative products to address unmet needs in women's sexual and reproductive health, has signed a license and supply agreement for the Middle East rights to Phexxi(R), Evofem's FDA-approved, hormone-free contra...